Does Rivastigmine Improve Cognitive Functions or Disability in Patients with Alzheimer’s Disease?

Publisher： Karger

E-ISSN： 1423-0208|23|4|209-210

ISSN： 0251-5350

Source： Neuroepidemiology, Vol.23, Iss.4, 2004-07, pp. : 209-210

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Rivastigmine in the Treatment of Alzheimer’s Disease

By  

European Neurology, Vol. 46, Iss. 2, 2001-08 ,pp. : 110-110

Karger

Access to resources Recommend Favorite

Medial Temporal Lobe Atrophy and APOE Genotype Do Not Predict Cognitive Improvement upon Treatment with Rivastigmine in Alzheimer’s Disease Patients

By  

Dementia and Geriatric Cognitive Disorders, Vol. 19, Iss. 2-3, 2005-02 ,pp. : 126-133

Karger

Access to resources Recommend Favorite

Disability in Instrumental Activities of Daily Living in Elderly Patients with Mild Cognitive Impairment and Alzheimer‘s Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 36, Iss. 3-4, 2013-07 ,pp. : 146-153

Karger

Access to resources Recommend Favorite

Effects of Medial Temporal Atrophy and White Matter Hyperintensities on the Cognitive Functions in Patients with Alzheimer’s Disease

By  

European Neurology, Vol. 66, Iss. 2, 2011-07 ,pp. : 75-82

Karger

Access to resources Recommend Favorite

Does Donepezil Improve Well-Being for Dementia due to Alzheimer’s Disease?

By  

Neuroepidemiology, Vol. 24, Iss. 3, 2005-04 ,pp. : 168-169

Karger

Access to resources Recommend Favorite